RedDress
RedDress Medical is at the forefront of innovative autologous wound care solutions, harnessing the power of whole blood to transform chronic, non-healing wound management. They are trusted by leading medical facilities and healthcare alliances, offering advanced, clinically proven healing solutions that support natural healing processes and deliver reliable outcomes. Their mission is to support healing in challenging wounds through cutting-edge research, peer-reviewed studies, and real-world case studies, aiming to improve patient quality of life and clinical results.
Industries
Nr. of Employees
small (1-50)
RedDress
Tel Aviv, Tel Aviv, Israel, Asia
Products
Autologous point-of-care whole blood clot system
A point-of-care system to produce an activated autologous whole blood clot for direct application to chronic, non‑healing wounds; the clot supplies a fibrin matrix, growth factors and cellular components to support wound healing.
Autologous point-of-care whole blood clot system
A point-of-care system to produce an activated autologous whole blood clot for direct application to chronic, non‑healing wounds; the clot supplies a fibrin matrix, growth factors and cellular components to support wound healing.
Services
Clinical case studies and outcome reporting
Development and publication of clinical case studies and outcome summaries documenting wound reduction and healing timelines across multiple patient cases.
Reimbursement information and coverage resources
Information and resources regarding Medicare and Medicare Advantage coverage eligibility for a blood-derived product for non-healing wounds (NCD 270.3).
Clinical case studies and outcome reporting
Development and publication of clinical case studies and outcome summaries documenting wound reduction and healing timelines across multiple patient cases.
Reimbursement information and coverage resources
Information and resources regarding Medicare and Medicare Advantage coverage eligibility for a blood-derived product for non-healing wounds (NCD 270.3).
Expertise Areas
- Chronic wound management
- Autologous therapeutics and biologics
- Point-of-care blood processing
- Clinical evidence generation and case-study documentation
Key Technologies
- Autologous whole blood clot therapy
- Nanoparticle-enabled blood activation
- Mold-based clot formation
- Fibrin matrix-based wound dressing